FORM 3
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  Niihara Yutaka
 2. Date of Event Requiring Statement (Month/Day/Year)
07/17/2019		 3. Issuer Name and Ticker or Trading Symbol
Emmaus Life Sciences, Inc. [EMMA]
(Last)
(First)
(Middle)
21250 HAWTHORNE BLVD., SUITE 800		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director __X__ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Chairman and CEO
 5. If Amendment, Date Original Filed(Month/Day/Year)
07/29/2019
(Street)

TORRANCE, CA 90503		 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common stock, $0.001 par value 10,163,793
D (1)
 
Common stock, $0.001 par value 10,501
I
By Soomi Niihara
Common stock, $0.001 par value 92,794
I
By Hope International Hospice, Inc. (2)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(Month/Day/Year)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock option 04/02/2012 04/02/2022 Common stock 262,536 $ 3.4281 D  
Stock option 02/28/2013 02/28/2023 Common stock 525,072 $ 3.4281 D  
Stock option 05/10/2016 05/10/2026 Common stock 315,043 $ 4.7613 D  
Common stock purchase warrant 09/30/2016 05/09/2021 Common stock 1,365,189 $ 4.7612 D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Niihara Yutaka
21250 HAWTHORNE BLVD.
SUITE 800
TORRANCE, CA 90503		   X   X   Chairman and CEO  

Signatures

Yutaka Niihara, M.D., M.P.H. 09/09/2019
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Includes shares owned jointly with Soomi Niihara, Dr. Niihara's wife.
(2) Hope International Hospice, Inc, is a California corporation of which Dr. Niihara and his wife are the sole shareholders and directors.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.